Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Safety Study in Patients With Advanced Solid Tumors

This study has been completed.
Information provided by (Responsible Party):
Eli Lilly and Company Identifier:
First received: January 19, 2011
Last updated: August 25, 2016
Last verified: August 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2016
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):